<DOC>
	<DOC>NCT01089569</DOC>
	<brief_summary>The primary purpose of this study is to compare the effect on 24-hour blood glucose patterns, HbA1c, and weight management when adding insulin glargine, or exenatide, or a combination of insulin glargine and exenatide to metformin.</brief_summary>
	<brief_title>Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine</brief_title>
	<detailed_description />
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Male or female subjects ≥18 and ≤75 years of age Clinical diagnosis of type 2 diabetes Diabetes duration ≥ 1 year HbA1c ≥7.0% Currently treated with metformin (HbA1c ≤9%) or metformin/sulfonylurea (SU) (HbA1c ≤8%)or SU alone (HbA1c ≤8%) Previously treated with insulin or incretinbased therapy Treated with a thiazolidinedione within past 6 weeks Taken oral or injected prednisone or cortisone medications in the previous 30 days Any pancreatic disease or at high risk of pancreatitis (history of alcohol abuse, active gallbladder disease) Serum creatinine &gt;1.4mg/dL (women) or &gt;1.5 mg/dL (men) eGFR &lt;30 ml/min (using MDRD equation ALT&gt;2xULN Presence of any severe medical or psychological condition or chronic conditions/infections that in the opinion of the Investigator would compromise he subject's safety or successful participation in the study Currently pregnant or planning pregnancy during the study period Unable to follow the study protocol Unable to speak, read and write in English Uncontrolled hyperglycemia with HbA1c &gt; 9% on metformin or &gt;8% on SU or metformin/SU combination or ketonuria requiring immediate insulin therapy At the investigator's discretion for other medical or psychological reasons</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>diabetes</keyword>
	<keyword>continuous glucose monitoring</keyword>
	<keyword>exenatide</keyword>
	<keyword>insulin glargine</keyword>
</DOC>